Published in Neurology on May 06, 2008
The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry (2013) 2.17
The relationship between blood pressure and cognitive function. Nat Rev Cardiol (2010) 1.66
The renin-angiotensin pathway in posttraumatic stress disorder: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms. J Clin Psychiatry (2012) 1.54
Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications. Psychoneuroendocrinology (2010) 1.24
Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review. Vasc Health Risk Manag (2010) 1.04
Angiotensin II AT(1) receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disorders. Cell Mol Neurobiol (2011) 1.02
Blood pressure and dementia - a comprehensive review. Ther Adv Neurol Disord (2009) 0.95
Role of central angiotensin receptors in scopolamine-induced impairment in memory, cerebral blood flow, and cholinergic function. Psychopharmacology (Berl) (2012) 0.90
Hypertension in the elderly. World J Cardiol (2012) 0.89
Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. Hypertension (2016) 0.87
Lessons from a mouse model characterizing features of vascular cognitive impairment with white matter changes. J Aging Res (2011) 0.86
Roles of Brain Angiotensin II in Cognitive Function and Dementia. Int J Hypertens (2012) 0.84
Effect of angiotensin II on spatial memory, cerebral blood flow, cholinergic neurotransmission, and brain derived neurotrophic factor in rats. Psychopharmacology (Berl) (2012) 0.84
Moving beyond the pros and cons of automating cognitive testing in pathological aging and dementia: the case for equal opportunity. Alzheimers Res Ther (2014) 0.80
Cognitive enhancement following acute losartan in normotensive young adults. Psychopharmacology (Berl) (2011) 0.79
Candesartan prevents impairment of recall caused by repeated stress in rats. Psychopharmacology (Berl) (2012) 0.78
A Comparison of Cognitive and Everyday Functional Performance among Older Adults With and Without Hypertension. Clin Gerontol (2013) 0.77
New spiral bacterium in gastric mucosa. J Clin Pathol (1989) 3.61
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage (2003) 2.67
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol (2007) 2.47
Serum 25-hydroxyvitamin D and cognitive decline in the very old: the Newcastle 85+ Study. Eur J Neurol (2014) 1.85
Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry (2006) 1.83
Are postal questionnaire surveys of reported activity valid? An exploration using general practitioner management of hypertension in older people. Br J Gen Pract (1999) 1.82
Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet (1994) 1.77
Management of older patients with hypertension in primary care: improvement on the rule of halves. Age Ageing (2001) 1.72
The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. Br J Psychiatry (2000) 1.61
Time relationships between cessation of smoking and onset of ulcerative colitis. Digestion (1987) 1.60
Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI. Neurology (2001) 1.59
Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa. J Antimicrob Chemother (1988) 1.57
Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial. Int Psychogeriatr (2001) 1.57
Agreement between ambulance paramedic- and physician-recorded neurological signs with Face Arm Speech Test (FAST) in acute stroke patients. Stroke (2004) 1.52
Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain (1999) 1.48
Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage (2002) 1.44
No evidence of an association between the T16189C mtDNA variant and late onset dementia. J Med Genet (2004) 1.40
Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology (2004) 1.38
Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology (2001) 1.34
Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology (2001) 1.32
Cognitive performance in hypertensive and normotensive older subjects. Hypertension (2000) 1.31
Calcium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev (2006) 1.29
Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav (2002) 1.28
Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry (2002) 1.28
Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology (2005) 1.28
Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology (2003) 1.28
Effects of aerobic exercise training and yoga on the baroreflex in healthy elderly persons. Eur J Clin Invest (1997) 1.26
Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology (2000) 1.22
Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry (2006) 1.21
Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord (2002) 1.20
MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. Neurology (2000) 1.19
Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord (2000) 1.18
Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology (1999) 1.16
Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Neurology (2000) 1.14
Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst Rev (2006) 1.14
Nitric oxide mediated venodilator effects of nebivolol. Br J Clin Pharmacol (1994) 1.13
Rapid ambulance protocol for acute stroke. Lancet (1999) 1.12
Intra-arterial thrombolysis for acute stroke in patients 80 and older: a comparison of results in patients younger than 80 years. AJNR Am J Neuroradiol (2007) 1.12
Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease. Alzheimer Dis Assoc Disord (1993) 1.11
Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. J Clin Endocrinol Metab (2000) 1.10
Sleep-disordered breathing following acute stroke. QJM (2002) 1.10
Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype. J Neurol Neurosurg Psychiatry (2008) 1.08
Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience (1995) 1.08
Depression with late onset is associated with right frontal lobe atrophy. Psychol Med (2003) 1.05
Do experienced diagnosticians agree about the diagnosis of dementia from survey data? The effects of informants' reports and interviewers' vignettes. Int J Geriatr Psychiatry (1998) 1.05
Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage (2003) 1.05
A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study. Dement Geriatr Cogn Disord (2001) 1.05
The role of levodopa in the management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry (2005) 1.05
The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology (Berl) (2000) 1.02
Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport (1994) 1.01
"We saw human guinea pigs explode". BMJ (2007) 1.01
Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects. Neurology (2004) 1.00
5HT2 receptor changes in major depression. Biol Psychiatry (1990) 1.00
IV thrombolysis and statins. Neurology (2011) 0.99
Matching-to-sample deficits in patients with senile dementias of the Alzheimer and Lewy body types. Arch Neurol (1992) 0.99
Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Neuroscience (2000) 0.98
Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial. Mov Disord (2001) 0.97
Mitochondrial function in muscle from elderly athletes. Ann Neurol (1997) 0.97
A double-blind, placebo controlled study of Ginkgo biloba extract ('tanakan') in elderly outpatients with mild to moderate memory impairment. Curr Med Res Opin (1991) 0.96
Gastrointestinal absorption of aluminium in Alzheimer's disease: response to aluminium citrate. Age Ageing (1992) 0.96
Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry (2006) 0.95
SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology (2004) 0.95
Dementia with Lewy bodies: diagnosis and management. Int J Geriatr Psychiatry (2001) 0.95
Tolerability of NXY-059 at higher target concentrations in patients with acute stroke. Stroke (2003) 0.95
Validity of a cognitive computerized assessment system in brain-injured patients. Brain Inj (1998) 0.95
Photodynamic therapy of ascites tumours within the peritoneal cavity. Br J Cancer (1986) 0.94
Salvia lavandulaefolia (Spanish sage) enhances memory in healthy young volunteers. Pharmacol Biochem Behav (2003) 0.94
Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord (1999) 0.94
Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults. Physiol Behav (2002) 0.94
Tolerability and pharmacokinetics of the nitrone NXY-059 in patients with acute stroke. Stroke (2001) 0.93
Neurobiology of motivation: double dissociation of two motivational mechanisms mediating opiate reward in drug-naive versus drug-dependent animals. Behav Neurosci (1992) 0.93
White matter disease and sleep-disordered breathing after acute stroke. Neurology (2003) 0.93
Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register. QJM (2008) 0.92
Defining hypertension in older people from primary care case notes review. J Hum Hypertens (1997) 0.92
Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD. Neurology (2000) 0.92
MRI volumetric correlates of white matter lesions in dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry (2000) 0.92
Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev (2006) 0.92
Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies. Neurology (2007) 0.92
A comparison of sleep profiles in patients with dementia with lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry (2000) 0.92
Nitric oxide activity in the peripheral vasculature during normotensive and preeclamptic pregnancy. Am J Physiol (1999) 0.92
Measurement of baroreflex gain from heart rate and blood pressure spectra: a comparison of spectral estimation techniques. Physiol Meas (1995) 0.91
Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord (2001) 0.91
Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias. Arch Neurol (1999) 0.90
Do differences in visuospatial ability between senile dementias of the Alzheimer and Lewy body types reflect differences solely in mnemonic function? J Clin Exp Neuropsychol (1995) 0.90
Water ingestion improves subjective alertness, but has no effect on cognitive performance in dehydrated healthy young volunteers. Appetite (2001) 0.90
Responsiveness of superficial hand veins to phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin therapy. J Clin Invest (1989) 0.90
Mechanism of bradykinin-induced venodilation in humans. J Cardiovasc Pharmacol (1993) 0.90
Doctors' attitudes towards the detection and treatment of hypertension in older people. J Hum Hypertens (1997) 0.89
Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. Dementia (1994) 0.89
Improved cognitive performance in human volunteers following administration of guarana (Paullinia cupana) extract: comparison and interaction with Panax ginseng. Pharmacol Biochem Behav (2004) 0.89
Metabolism of phosphonoacetate as the sole carbon and phosphorus source by an environmental bacterial isolate. Appl Environ Microbiol (1992) 0.89
Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[18F]fluoro-A-85380 PET study. Neurobiol Learn Mem (2008) 0.88
Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers. Physiol Behav (2005) 0.88
In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies. Lancet (1999) 0.87
Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer's disease: an MRI study. Neurology (2003) 0.87
Responsiveness of superficial hand veins to alpha-adrenoceptor agonists in insulin-dependent diabetic patients. Clin Sci (Lond) (1992) 0.87
The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: persistence and new cases over 1 year of follow-up. J Clin Psychiatry (2001) 0.87